Pulmonx Corp. (LUNG) PT Lowered to $46 at Piper Sandler
Tweet
Share
E-mailGet Alerts LUNG Hot Sheet
Price: $2.32 +1.31%
Rating Summary:
5 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
5 Buy, 4 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
Piper Sandler analyst Jason Bednar lowered the price target on Pulmonx Corp. (NASDAQ: LUNG) to $46.00 (from $50.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$440 at Macquarie
- JPMorgan Upgrades KCE Electronics PCL (KCE:TB) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
